array(2) { ["lab"]=> string(4) "1140" ["publication"]=> string(5) "12881" } Misshapen Disruption Cooperates with RasV12 to Drive Tumorigenesis - 信号转导与细胞通讯实验室 | LabXing

信号转导与细胞通讯实验室

简介 马仙珏实验室

分享到

Misshapen Disruption Cooperates with RasV12 to Drive Tumorigenesis

2021
期刊 Cells
下载全文
Although RAS family genes play essential roles in tumorigenesis, effective treatments targeting RAS-related tumors are lacking, partly because of an incomplete understanding of the complex signaling crosstalk within RAS-related tumors. Here, we performed a large-scale genetic screen in Drosophila eye imaginal discs and identified Misshapen (Msn) as a tumor suppressor that synergizes with oncogenic Ras (RasV12) to induce c-Jun N-terminal kinase (JNK) activation and Hippo inactivation, then subsequently leads to tumor overgrowth and invasion. Moreover, ectopic Msn expression activates Hippo signaling pathway and suppresses Hippo signaling disruption-induced overgrowth. Importantly, we further found that Msn acts downstream of protocadherin Fat (Ft) to regulate Hippo signaling. Finally, we identified msn as a Yki/Sd target gene that regulates Hippo pathway in a negative feedback manner. Together, our findings identified Msn as a tumor suppressor and provide a novel insight into RAS-related tumorigenesis that may be relevant to human cancer biology.